1. Home
  2. CSBR vs MDXH Comparison

CSBR vs MDXH Comparison

Compare CSBR & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • MDXH
  • Stock Information
  • Founded
  • CSBR 1985
  • MDXH 2003
  • Country
  • CSBR United States
  • MDXH Belgium
  • Employees
  • CSBR N/A
  • MDXH N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • MDXH
  • Sector
  • CSBR Health Care
  • MDXH
  • Exchange
  • CSBR Nasdaq
  • MDXH Nasdaq
  • Market Cap
  • CSBR 123.2M
  • MDXH 118.3M
  • IPO Year
  • CSBR 1986
  • MDXH 2021
  • Fundamental
  • Price
  • CSBR $6.75
  • MDXH $2.48
  • Analyst Decision
  • CSBR Strong Buy
  • MDXH Buy
  • Analyst Count
  • CSBR 1
  • MDXH 1
  • Target Price
  • CSBR $12.00
  • MDXH $6.00
  • AVG Volume (30 Days)
  • CSBR 39.7K
  • MDXH 68.9K
  • Earning Date
  • CSBR 09-10-2025
  • MDXH 08-20-2025
  • Dividend Yield
  • CSBR N/A
  • MDXH N/A
  • EPS Growth
  • CSBR N/A
  • MDXH N/A
  • EPS
  • CSBR 0.33
  • MDXH N/A
  • Revenue
  • CSBR $56,944,000.00
  • MDXH $94,507,000.00
  • Revenue This Year
  • CSBR $9.30
  • MDXH $23.41
  • Revenue Next Year
  • CSBR $31.17
  • MDXH $18.50
  • P/E Ratio
  • CSBR $19.52
  • MDXH N/A
  • Revenue Growth
  • CSBR 13.54
  • MDXH 25.46
  • 52 Week Low
  • CSBR $3.60
  • MDXH $1.35
  • 52 Week High
  • CSBR $11.99
  • MDXH $3.50
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 41.70
  • MDXH 61.81
  • Support Level
  • CSBR $5.85
  • MDXH $2.34
  • Resistance Level
  • CSBR $6.74
  • MDXH $2.55
  • Average True Range (ATR)
  • CSBR 0.54
  • MDXH 0.12
  • MACD
  • CSBR -0.14
  • MDXH -0.00
  • Stochastic Oscillator
  • CSBR 26.08
  • MDXH 51.00

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: